Search Results for: "amgen v. hospira"

Huon Announces Prolia Biosimilar

On April 20, 2021, Korean company Huon Labs announced that it will develop a PROLIA biosimilar using PanGen Biotech’s cell culture and purification technology. PROLIA (denosumab), an Amgen product, is…

Read More

Q4 2020 and Full Year Earnings Roundup: Biologics and Biosimilars Update

…offset by biosimilar competition for Amgen’s mature products. Amgen also reported full year revenues increased 9% to $25.4 billion. Specifically, Amgen reported that MVASI generated $280 million of sales in…

Read More